Market Overview

Earnings Preview: AstraZeneca


AstraZeneca (NYSE: AZN) announces its next round of earnings this Thursday, July 30. Here is Benzinga's everything-that-matters guide for this Thursday's Q2 earnings announcement.

Earnings and Revenue

Wall Street expects EPS of $0.44 and sales around $6.28 billion. In the same quarter last year, AstraZeneca reported earnings per share of $0.730 on sales of $5.82 billion. If the company were to report in-line earnings when it publishes results Thursday, earnings would be down 39.73%. Revenue would be up 6.44% from the year-ago period. AstraZeneca's reported EPS has stacked up against analyst estimates in the past like this:

Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019
EPS Estimate 0.47 0.59 0.45 0.29
EPS Actual 1.05 0.89 0.99 0.73
Revenue Estimate 5.90 B 6.75 B 6.18 B 5.51 B
Revenue Actual 6.35 B 6.66 B 6.41 B 5.82 B

Stock Performance

Shares of AstraZeneca were trading at $56.3 as of July 29. Over the last 52-week period, shares are up 28.27%. Given that these returns are generally positive, long-term shareholders are probably happy going into this earnings release.

Don't be surprised to see the stock move on comments made during its conference call. AstraZeneca is scheduled to hold the call at 06:45:00 ET and can be accessed here:


Related Articles (AZN)

View Comments and Join the Discussion!

Posted-In: Earnings